Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy
- PMID: 8774145
- PMCID: PMC1861719
Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy
Abstract
Immunohistochemical studies were performed to determine the presence and distribution of polypeptide transforming growth factor (TGF)-beta 1, a cytokine with macrophage-suppressing activity, in skin biopsies from 41 patients with different clinical forms of leprosy. We used an anti-TGF-beta 1 polyclonal antibody and the avidinbiotin-peroxidase (ABC complex) method. The results demonstrated that the lesions of the lepromatous and borderline lepromatous forms presented intense cytoplasm staining for TGF-beta 1 in the cells of the dermal infiltrate. A reaction of moderate intensity was observed in the cells of granulomas from borderline borderline cases, whereas no detectable immunoreaction was observed in granuloma cells from the tuberculoid and borderline tuberculoid forms. Considering that in the lepromatous leprosy form Mycobacterium leprae multiplies in the cytoplasm of macrophages and the lesions are diffuse and consist of poorly differentiated young macrophages, we believe that these alternations may be explained at least in part by the presence of TGF-beta 1 in the dermal infiltrate. Production of the cytokine may be induced by the presence of the bacillus itself and of its constituents, causing a mechanism of parasite evasion. Similarly, the absence of TGF-beta 1 in tuberculoid leprosy, which progresses with a specific immune response to M. leprae, may explain the intense differentiation of macrophage cells with the formation of well defined epithelioid granulomas capable of eliminating most of the bacilli.
Similar articles
-
In vitro and skin lesion cytokine profile in Brazilian patients with borderline tuberculoid and borderline lepromatous leprosy.Lepr Rev. 2011 Mar;82(1):25-35. Lepr Rev. 2011. PMID: 21644469
-
Distinct patterns of microvasculature in the cutaneous lesions of leprosy.Int J Lepr Other Mycobact Dis. 2000 Jun;68(2):143-51. Int J Lepr Other Mycobact Dis. 2000. PMID: 11036494
-
Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.Br J Dermatol. 2007 Aug;157(2):273-83. doi: 10.1111/j.1365-2133.2007.07992.x. Epub 2007 Jun 6. Br J Dermatol. 2007. PMID: 17553031
-
Histopathology of the lepromatous skin biopsy.Clin Dermatol. 2015 Jan-Feb;33(1):38-45. doi: 10.1016/j.clindermatol.2014.10.003. Clin Dermatol. 2015. PMID: 25432809 Review.
-
Inside the skin: the local immune and inflammatory milieu in leprosy.Am J Trop Med Hyg. 1991 Apr;44(4 Pt 2):17-23. Am J Trop Med Hyg. 1991. PMID: 2042708 Review.
Cited by
-
Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.Clin Exp Immunol. 2000 Dec;122(3):330-4. doi: 10.1046/j.1365-2249.2000.01376.x. Clin Exp Immunol. 2000. PMID: 11122237 Free PMC article.
-
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts.Mem Inst Oswaldo Cruz. 2024 Feb 19;119:e230129. doi: 10.1590/0074-02760230129. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 38381878 Free PMC article.
-
Description of electroneuromiographic and laboratorial findings in leprosy neuropathy, according to its clinical forms: the confirmation of a spectral disease.Front Med (Lausanne). 2024 Jan 8;10:1304131. doi: 10.3389/fmed.2023.1304131. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38259847 Free PMC article.
-
Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects.PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006086. doi: 10.1371/journal.pntd.0006086. eCollection 2017 Nov. PLoS Negl Trop Dis. 2017. PMID: 29176796 Free PMC article.
-
Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions.Clin Exp Immunol. 1998 Sep;113(3):438-42. doi: 10.1046/j.1365-2249.1998.00669.x. Clin Exp Immunol. 1998. PMID: 9737674 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources